Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.42 and traded as low as $0.1004. Eagle Pharmaceuticals shares last traded at $0.70, with a volume of 2,604 shares changing hands.
Eagle Pharmaceuticals Price Performance
The business has a 50-day moving average of $1.43 and a 200-day moving average of $2.42. The company has a market capitalization of $9.09 million, a P/E ratio of 0.59 and a beta of 0.83.
Eagle Pharmaceuticals Company Profile
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
Recommended Stories
- Five stocks we like better than Eagle Pharmaceuticals
- How to Read Stock Charts for Beginners
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
